Background: Unnecessary use of antibiotics is a common occurrence in hospitals. Implementation of antibiotic stewardship programs (ASPs) has been shown to reduce both unnecessary antibiotic use and drug-resistant bacteria. Education is a fundamental component of an ASP. However, the effectiveness of proper uses of antibiotics education has not been clearly analyzed. Methods: In a 520-bed university hospital located in northeastern Taiwan, a significantly increasing prescription of carbapenems, specifically imipenem and meropenem, was observed. An educational program highlighting the judicious use of carbapenems was started, beginning in October 2013. A multidisciplinary ASP was implemented starting in January 2014. The consumption of antibiotics, measured by defined daily dose per 1000 occupied bed-days, was compared among the pre-educational, posteducational, and post-ASP periods. Results: Compared with the pre-educational period, there was a significant reduction in antibiotics consumption of 13% total inpatient antibiotics ( p ¼ 0.008), 29.8% carbapenems ( p ¼ 0.001), 34.9% imipenem and meropenem ( p < 0.001), and 27% glycopeptides ( p ¼ 0.015), in the posteducational and post-ASP periods. The major reduction emerged during the posteducational period and was sustained after the ASP. The percentage of inpatients prescribed with antibiotics was significantly decreased (16.2%; p < 0.001). The rate of carbapenem-resistant Acinetobacter baumannii decreased from 70.8% to 29.6% within 7 months. Conclusion: A focused educational program is effective in controlling the prescription of specific antibiotic classes in the early phase of a multidisciplinary ASP.
Introduction
Misuse of antibiotics is a common occurrence in hospitals. It was estimated that up to 40e50% of antibiotic use did not abide by local and national antibiotic guidelines or was discordant with microbiological results. 1, 2 Patients are placed at additional risk for adverse effects when exposed to unnecessary antibiotics, including Clostridium difficile infection, a potentially life-threatening infection associated with antibiotic therapy. 3 Another major problem of antibiotic use is the selection of drug-resistant bacteria, particularly multidrugresistant organisms. 4, 5 Overuse of antimicrobial agents exerts excessive selection pressures on the targeted as well as the bystander microbes that are exposed to the drugs. 6 Alteration of the expression of genes regulating drug resistance is observed when microbes are exposed to antibiotics, 7 and antimicrobial agents play complex roles in that they inhibit microbes while inducing resistance, and even help in dissemination of resistance at the same time. 8 Multidrugresistant organisms are increasingly being recognized as a global public health issue. 9 Healthcare-associated infection and antimicrobial resistance that significantly increase morbidity, mortality, and medical costs are current challenges to the treatment of infectious diseases in Taiwan. 1 Implementation of antibiotic stewardship programs (ASPs) has been shown to effectively reduce unnecessary antibiotic use and optimize the treatment of infectious diseases. 5 The World Health Organization strongly recommends that governments implement ASPs for the containment of antimicrobial resistance. 10 Following the reduction of antibiotic consumption, a decrease in the rate of drug-resistant bacteria is expected. 11, 12 To be successful, multiple aspects should be considered in an ASP. Several "core elements" have been suggested by the Center of Disease Control of the United States, including leadership commitment to dedicate necessary resources, appointing an accountable leader responsible for program outcomes, drug expertise to improve antibiotic use, actions to support optimal antibiotic use, tracking and monitoring antibiotic use and resistance, and reporting information to staff on improving antibiotic use and resistance. 13 A systemic education program is one of the essential components that comprise an ASP, 14, 15 although education alone is only marginally effective unless it is incorporated with other control measures. 16 Regular education and training furnish prescribers with fundamental knowledge on drug resistance bacteria, principles of antibiotic use, and infectious disease management, whereas a theme-based educational program provides a platform for stressing facility-specific issues and influencing prescribers' behavior. Recently, implementation of an education-based ASP was shown to improve antimicrobial prescriptions and consumption, even when restrictive measures were not implemented. 17 Here, we demonstrate the effectiveness of an educational program targeting primary prescribers to control the consumption of specific antibiotic classes in the early phase of a multidisciplinary ASP.
Methods
2.1. Setting, surveillance, and antibiotic control measures prior to multidisciplinary ASP National Yang-Ming University Hospital (YMUH) is a 520-bed university hospital located in northeastern Taiwan. Antimicrobial agents are classified as "restricted" or "nonrestricted" at YMUH. Restricted agents include third-and fourth-generation cephalosporins, extended-spectrum penicillins, carbapenems, glycopeptides, fluoroquinolones, oxazolidinones (linezolid), colistin, daptomycin, and glycylcyclines (tigecycline). On a hospital-wide basis, prescription of restricted antimicrobial agents requires approval from an infectious diseases (ID) physician. An online antimicrobial control system was deployed since July 2012. Through the Health Information System, the ID physician reviews the clinical and laboratory presentation, reports of cultures, and images of each patient to whom the restricted antibiotics are prescribed. Should a decision of disapproval be made, the antimicrobial will be discontinued by the unit-dose delivery system after 48 hours. The prescribers will be notified immediately to modify the prescription. Nonrestricted antimicrobial agents do not require approval from an ID physician.
The ID pharmacists in YMUH started surveillance of antimicrobial consumption in 2008 and have reported their analysis to the Infection Control Committee of YMUH at its quarterly meeting. Since 2012, a gradual increase in the consumption of carbapenems, mainly imipenem and meropenem, has been observed. In May 2013, decreasing the use of imipenem and meropenem was advocated in a hospital-wide meeting with all attending physicians participating. However, the effect was marginal, and the trend of increasing consumption of carbapenems continued. The study was approved exempt review of research by the authors' institutional review board (IRB No. 2014A030).
Education on the antibiotic stewardship concept prior to ASP
Systemic education has been provided in YMUH to ensure good quality of antibiotic therapy. All physicians were asked to attend at least one of the semiannual speeches on the rationale and principles of antibiotic therapy. The control policy for both restricted and nonrestricted antibiotics was described.
In YMUH, the primary prescribers of antimicrobial agents of the admitted patient are usually the in-charge or on-duty residents, whose prescriptions are reviewed by the attending physicians. The monthly rotating intern and resident physicians are requested to attend an educational program directed by the ID physicians. Since October 2013, an educational program on the concept of antibiotic stewardship highlighting judicious use of imipenem and meropenem were introduced to the monthly lesson for interns and resident physicians. The attendees were presented with cases of appropriate and inappropriate use of both antibiotics, and were encouraged to telephone-consult the ID physicians prior to the prescription of carbapenems.
Implementation of multidisciplinary ASP
As part of the nationwide ASP conducted by the Centers for Disease Control of Taiwan, the multidisciplinary ASP of YMUH, began on since January 17, 2014 and has been ongoing continually since then. 14 The Institutional Review Board of YMUH deemed the ASP as a quality improvement activity that did not require ethical approval. The previous antibiotic control system was continued, with major reinforcement of pharmacists' participation. On a daily basis, ID pharmacists reviewed the appropriateness, dosage, frequency, and treatment duration of prescribers' cases and reported to the online computerized antibiotic control system. The prescribers would be telephone-called if an ID pharmacist identified inappropriate antimicrobial use. Three times a week, an ID pharmacist would discuss the antimicrobial prescriptions with the ID physician and join ward rounds with the physician. Adverse drug reactions and drugedrug interactions were consulted on as needed. Prescribers who followed major inappropriate principles in antimicrobial use were asked to join the discussion.
Data collection and statistical analysis
Retrospectively, hospital-wide consumption of antibiotic agents and data on drug-resistant bacteria prior to and after implementation of ASP were collected for analysis. The Anatomical, Therapeutic, and Chemical classification system and the defined daily dose (DDD) were used to measure the consumption of antimicrobial agents. The rate of DDDs per 1000 patient-days per month was calculated. None of the individual patient data was accessed in this study. A p value <0.05 indicated a significant difference. All analyses were carried out using Microsoft Excel 2010 (Microsoft Corp., Redmond, WA, USA) and SPSS 18.0 for Windows (IBM-SPSS, Inc., Chicago, IL, USA).
Results

A significant decrease in the consumption of carbapenems was found after implementation of multidisciplinary ASP
The use of major classes of restricted antibiotics prior to and after the ASP was reviewed. The antibiotic consumption data for the year 2013 (the pre-ASP period) and January through June of 2014 (the post-ASP period) were compared. There was a significant decrease of more than 30% (31. Fig. 1 ), specifically imipenem and meropenem, for which there was more than 35% (35.19%) reduction (28.7 ± 1.4 vs. 18.6 ± 2.5 DDD per 1000 patient-days, p ¼ 0.001). There were no significant changes in consumption between the two periods in glycopeptides, fluoroquinolones, and total inpatient antibiotic use. In the post-ASP period, there was an increase of more than 30% (32.02%) in consumption of piepracillin/tazobactam (32.02%, 24.2 ± 1.2 vs. 35.6 ± 6.3 DDD per 1000 patient-days, p ¼ 0.025) and in consumption of third-and fourth-generation cephalosporins (31.72%, 39.6 ± 1.8 vs. 58.0 ± 4.9 DDD per 1000 patient-days, p < 0.001).
The percentage of inpatients prescribed with antibiotics was significantly decreased, 16.2% (61.9 ± 0.77 vs. 51.9 ± 0.99%, p < 0.001). After ASP, the inpatient antibiotics costs account of total drug costs decreased from 53.4% to 51.9% ( p ¼ 0.200). However, the mean monthly costs showed no reduction change, from US$17,069 to US$16,346 per 1000 patient-days ( p ¼ 0.43) (US$1 ¼ NT$32.206). The mortality rate decreased from 3.5% to 3.1% ( p ¼ 0.126).
Consumption of imipenem, meropenem, and glycopeptides decreased after initiation of the educational program
We further analyzed the changes in antibiotic consumption prior to and after the educational program particularly designed for major prescribers. Compared with the 9-month pre-educational period, the consumption of imipenem and meropenem, carbapenems, and glycopeptides decreased significantly within the first 3 months of the educational program. When the consumption of antibiotics in the 3-month posteducational and the 6-month post-ASP periods were combined, a significant decrease was observed in the use of imipenem and meropenem (34.9%), carbapenems (29.8%), glycopeptides (27.0%), and total inpatient antibiotics (13.5%), as shown in Fig. 2 . The percentage of patients prescribed antibiotics among inpatients was significantly decreased (9.0 %) (61.3 ± 0.80% vs. 55.8 ± 2.1%, p ¼ 0.025). Change in the consumption of carbapenems associated with major interventions is illustrated in Fig. 3. 
A gradual and steady decrease in carbapenemresistant Acinetobacter baumannii was observed after the implementation of multidisciplinary ASPs
In YMUH, the rate of carbapenem-resistant A. baumannii (CRAB) has increased in recent years, reaching its highest level of 70.8% in January 2014. After the implementation of multidisciplinary ASP, a gradual, steady decrease in the ratio of CRAB was observed, falling below 30% in July 2014 (Fig. 4) . No significant changes were found in the rate of carbapenem-resistant Pseudomonas aeruginosa, methicillinresistant Staphylococcus aureus, or vancomycin-resistant Enterococcus. Carbapenem-resistant Enterobactereaceae was below 2% prior to 2013, but significantly increased to 12.4% in June 2014.
Discussion
In this study, we clearly demonstrated that a focused educational program for primary prescribers helped reduce the consumption of total inpatient antibiotics and specific antimicrobial agents (imipenem, meropenem and glycopeptides) within a short period. Although a growing body of evidence suggests that a successful ASP requires a coordinated multidisciplinary approach including different measures, the effect of an individual measure is usually unclear, because multiple control measures are often initiated at the same time. However, interinstitutional variation may exist in either patient safety culture or prescribing behavior. An ASP that proved successful in one institute may be confronted with difficulties in another because of cultural differences. Institutions should adopt the strategies that are more likely to succeed and the measures that are most cost-effective.
Based on the national database of antimicrobial resistance from the Taiwan Nosocomial Infection Surveillance System during the period 2003e2012, the proportion of A. baumannii isolates resistant to imipenem or meropenem increased from 17.2% to 72.8%. 14 In YMUH, an increase in the use of carbapenems was observed in recent years. The increasing consumption of carbapenems was clearly associated with a steady rise in the rate of CRAB (up to 70.8% in January 2014), of which the majority was resistant to imipenem and meropenem. Although infection control measures including isolation of colonized patients, environmental cleaning, and hand hygiene promotion had been reinforced in the past decade, the effect was only marginal and the rate of CRAB continued to rise. Theoretically, clinicians are supposed to treat patients according to guidelines that have taken into account both the antibiotics effectiveness and the development of resistance of antimicrobials. However, in clinical practice, prescribers are generally more concerned about the effects, but not the resistance of, antimicrobial therapy. 15 The usual scenario is that broad-spectrum antibiotics such as imipenem or meropenem are selected when the patient is unstable and continue to be used unless microbiological studies show clear evidence for de-escalation.
Education is part of the foundation for a successful ASP. 16, 17 A well-designed educational program provides prescribers with updated knowledge on antimicrobial use, drug resistance, and infectious disease management. 8, 17 Educational interventions have been shown to improve prescribing competency, change prescribing habits, and help prescribers adhere to guidelines. 18 In an ASP, institution-based education programs can also integrate local data with national guidelines and encourage antimicrobial therapies that are appropriate or preferred for the institution. 1, 19 When appropriate regimens are not usually selected by the primary prescribers, such programs may influence clinicians' prescription during their evaluation of the patient and help to preserve other stewardship strategies such as formula restriction or reviewing. In YMUH, the concept of the judicious use of carbapenems was conveyed to the main prescribing clinicians through monthly academic meeting by the ID physician. Cases of both appropriate and inappropriate antibiotic use were discussed in the session. The logic of the thinking process for clinicians in the empirical use of antimicrobials was not exclusively targeted toward broad-spectrum antibiotics and an effective deescalation strategy based on a patient's unique culture result. Educational models that encourage reflection on practice, and small-group learning and discussions, are more likely to change behaviors. 20 Another noteworthy finding is that, concordant with the reduced consumption of carbapenems, there was a swift decrease in the rate of CRAB almost immediately after the initiation of multidisciplinary ASP. Although multiple measures such as hand hygiene and environmental cleaning were promoted in the ASP, the most dramatic changes in this early phase was the decreased use of carbapenems. CRAB has emerged as an important pathogen in the hospitals of Taiwan. 1 The increase in infections caused by CRAB has been directly linked to the use of antipseudomonal carbapenems. 21 Our finding suggests that restriction in the use of antipseudomonal carbapenems would be an effective measure to control the increase of CRAB. Interestingly, such effect was not found in other drug-resistant bacteria including carbapenem-resistant Pseudomonas aeruginosa and Enterobateriaceae. Whether the carbapenem-control strategy is pathogen-specific should be further studied.
There are several limitations in our study. First, the data were collected retrospectively in a single hospital with a small sample size and a short study period, which made it difficult to access the clinical and epidemiological impact of the program. Also, such analysis was unable to evaluate the changed behavior of prescribing clinicians. More objective tools are needed.
In conclusion, our study suggests that a focused educational program targeting the major prescribing clinicians is effective in controlling a specific antibiotic class and the microorganism resistant to it. Such effect becomes obvious in the early phase of an ASP. A well-designed, theme-based educational program should be an important tool to achieve institution-specific aims in an ASP.
